4-BENZYL-2-HYDROXY-MORPHOLIN-3-ONE CAS:287930-75-0
The molecular structure of 4-Benzyl-2-hydroxy-morpholin-3-one comprises a morpholinone core substituted with a benzyl group at the 4-position and a hydroxyl group at the 2-position. This specific arrangement imparts crucial physicochemical properties essential for pharmaceutical applications, including solubility, stability, and reactivity. The presence of the benzyl and hydroxyl groups enhances the compound's potential interactions with biological targets, influencing its pharmacological efficacy. Synthesis and Applications Synthesis of 4-Benzyl-2-hydroxy-morpholin-3-one typically involves multi-step procedures starting from commercially available starting materials. Common synthetic routes may include morpholinone ring formation followed by benzyl group introduction via suitable coupling reactions and subsequent hydroxylation. The synthesized compound finds applications in medicinal chemistry as a scaffold for developing potential drug candidates targeting various diseases. Pharmaceutical Relevance In medicinal chemistry, derivatives of 4-Benzyl-2-hydroxy-morpholin-3-one exhibit promising pharmacological activities, including antimicrobial and antitumor properties. The compound's molecular architecture allows for specific interactions with biological targets, making it valuable for the synthesis of novel therapeutic agents. Researchers explore its structural diversity to optimize pharmacokinetic profiles and enhance therapeutic efficacy, addressing critical medical needs and advancing drug discovery efforts. Therapeutic Potential The diverse pharmacological profile of derivatives of 4-Benzyl-2-hydroxy-morpholin-3-one positions them as promising candidates for treating infectious diseases and cancers. The compound's ability to modulate specific molecular pathways underscores its therapeutic potential, driving ongoing research efforts to elucidate its mechanisms of action and optimize clinical outcomes in targeted therapies. Conclusion In conclusion, 4-Benzyl-2-hydroxy-morpholin-3-one emerges as a pivotal compound with significant implications in medicinal chemistry and drug discovery. Its unique molecular structure and diverse pharmacological activities make it a valuable tool for researchers aiming to develop innovative therapies for a wide range of medical conditions. As scientific investigations into its biological properties and synthetic methodologies progress, further insights are anticipated to accelerate its translation into clinical applications, ultimately benefiting global healthcare efforts.
Composition | C11H13NO3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 287930-75-0 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |